RSRC1: A Plant-derived Compound with Anti-inflammatory and Antioxidant Effects

Target Name: RSRC1

NCBI ID: G51319

RSRC1

RSRC1: A Plant-derived Compound with Anti-inflammatory and Antioxidant Effects

RSRC1 (Resveratrol sulfone homolog 1) is a plant-derived natural compound that has been found to have various health benefits, including anti-inflammatory and antioxidant effects. It is also a drug target and a potential biomarker for various diseases, making it an attractive target for drug development.

TheRSRC1 gene, which encodes the protein RSRC1, is located on chromosome 1 and encodes a protein of approximately 21 kDa. The protein is composed of two distinct domains: N-terminal and C-terminal. The N-terminal domain contains a conserved nucleotide sequence that is commonly found in proteins that are involved in cell signaling pathways, while the C-terminal domain contains a conserved helical region that is involved in protein-protein interactions and a unique disulfide bond that is characteristic of the protein family of cytoplasmic proteins.

RSRC1 has been shown to have a variety of health benefits, including anti-inflammatory and antioxidant effects. The anti-inflammatory effects of RSRC1 are mediated by its ability to inhibit the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6. These cytokines are responsible for promoting the recruitment and activation of immune cells, which can cause inflammation and contribute to a variety of diseases, including heart disease, cancer, and neurodegenerative diseases.

In addition to its anti-inflammatory effects, RSRC1 has also been shown to have antioxidant properties. The antioxidant effects of RSRC1 are mediated by its ability to donate a reactive sulfur group, which can accept electrons from other molecules and reduce their oxidation state. This ability to donate sulfur ions makes RSRC1 a potent antioxidant, and it has been shown to protect cells from oxidative stress caused by free radicals.

The potential drug targets for RSRC1 are numerous. For example, it has been shown to be involved in a variety of signaling pathways, including cell signaling pathways, DNA repair pathways, and stress signaling pathways. It is also involved in the production of various signaling molecules, including activating transcription factor-3 (ATF-3), which is involved in cell growth and proliferation, and nuclear factor-kB (NF-KB), which is involved in inflammation.

In addition to its potential drug targets, RSRC1 is also a potential biomarker for a variety of diseases. For example, it has been shown to be involved in the development and progression of cancer, including breast cancer, lung cancer, and colon cancer. It is also involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

The drug development process for RSRC1 is currently ongoing. Researchers are studying the potential clinical applications of RSRC1, including its potential as a cancer and neurodegenerative disease drug. Initial studies have shown that RSRC1 is effective in inhibiting the production of pro-inflammatory cytokines and protecting cells from oxidative stress. Further studies are needed to determine its safety and efficacy as a drug.

In conclusion, RSRC1 is a plant-derived natural compound that has been found to have various health benefits, including anti-inflammatory and antioxidant effects. Its unique disulfide bond and conserved nucleotide sequence make it an attractive target for drug development. Further studies are needed to determine its safety and effectiveness as a drug, and its potential as a biomarker for various diseases.

Protein Name: Arginine And Serine Rich Coiled-coil 1

Functions: Has a role in alternative splicing and transcription regulation (PubMed:29522154). Involved in both constitutive and alternative pre-mRNA splicing. May have a role in the recognition of the 3' splice site during the second step of splicing

The "RSRC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RSRC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets